The antituberculous activity of rifamycin SV.
D000328:Adult; D000818:Animals; D004352:Drug Resistance, Microbial; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D013902:Radiography, Thoracic; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D012293:Rifampin